These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32609)

  • 21. Crossover comparison of benoxaprofen and naproxen in osteoarthritis.
    Blechman WJ
    J Rheumatol Suppl; 1980; 6():116-24. PubMed ID: 6993667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fast-dissolving sublingual tablets of piroxicam versus naproxen in the treatment of recurrent acute osteoarthrosis. Multicenter clinical trial].
    Consoli G; Covelli M; Di Matteo L; Marcolongo R; Tirri G; La Montagna G; Pipitone V
    Minerva Med; 1994 Mar; 85(3):89-96. PubMed ID: 8196849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-masked comparison of Naprelan and nabumetone in osteoarthritis of the knee. Naprelan Study Group.
    Fleischmann RM; Flint K; Constantine G; Kolecki B
    Clin Ther; 1997; 19(4):642-55. PubMed ID: 9377610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benorylate: a report on 2 years' experience of its use in rheumatoid arthritis and other chronic rheumatic diseases.
    Hingorani K
    Scand J Rheumatol Suppl; 1975; 13():29-32. PubMed ID: 8837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A placebo-controlled, double-blind trial of Benorylate tablets in the treatment of bursitis and synovitis due to sports injury.
    Krishnan G
    Rheumatol Rehabil; 1977 Aug; 16(3):186-9. PubMed ID: 20656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Italian double-blind multicenter study comparing S-adenosylmethionine, naproxen, and placebo in the treatment of degenerative joint disease.
    Caruso I; Pietrogrande V
    Am J Med; 1987 Nov; 83(5A):66-71. PubMed ID: 3318442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind, parallel trial of oxaprozin versus naproxen in the treatment of osteoarthritis.
    Ginsberg F; Famaey JP
    Curr Med Res Opin; 1984; 8(10):689-95. PubMed ID: 6373152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled-release naproxen compared with isoxicam in patients with osteoarthritis.
    Frankhof W
    Curr Med Res Opin; 1988; 11(1):28-33. PubMed ID: 3289830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of a slow-release indomethacin tablet and naproxen in osteoarthrosis.
    Gordin A; Sotka S; Nuutila J
    Curr Med Res Opin; 1985; 9(7):500-4. PubMed ID: 3896659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical study of a new anti-inflammatory and analgesic compound, benorylate, in rheumatic disorders.
    Doury P; Pattin S
    Scand J Rheumatol Suppl; 1975; 13():33-6. PubMed ID: 8838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical evaluation of a new controlled-release formulation of naproxen in osteoarthritis and rheumatoid arthritis. Canadian Multicentre Study Group.
    Curr Med Res Opin; 1988; 11(1):16-27. PubMed ID: 2898319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind comparative evaluation of tolmetin versus naproxen in osteoarthritis.
    Telhag H; Bach-Andersen R; Persson B
    Curr Med Res Opin; 1981; 7(6):392-400. PubMed ID: 7016451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naproxen in osteoarthrosis. Double-blind crossover trial.
    Blechman W; Willkens R; Boncaldo GL; Hoffmeister RT; Lockie LM; Multz C
    Ann Rheum Dis; 1978 Feb; 37(1):80-4. PubMed ID: 343726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naproxen vs. aspirin in osteoarthritis of the hip and knee.
    Melton JW; Lussier A; Ward JR; Neustadt D; Multz C
    J Rheumatol; 1978; 5(3):338-46. PubMed ID: 372525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of naproxen, indomethacin and aspirin in osteoarthritis.
    Martinez-Lavin M; Holman KI; Smyth CJ; Vaughan JH
    J Rheumatol; 1980; 7(5):711-6. PubMed ID: 7441660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diflunisal versus naproxen in the management of rheumatoid arthritis.
    Osborn TG; Parks RL; Moore TL; Grisanti MW; Nesher G; Caciolo BA
    Clin Ther; 1989; 11(6):736-43. PubMed ID: 2692819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteoarthritis and non-steroidal and anti-inflammatory drugs: a multi-centre comparative study.
    Pathy MS
    Curr Med Res Opin; 1982; 7(Suppl 1):41-52. PubMed ID: 7105795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enteric coated naproxen; a double blind trial comparing the tolerance of enteric coated and standard formulations.
    Huskisson EC; Bernstein RM; Coppock JS; Davies PG; Doyle DV; Platt PR; Scott DL; Witherington RH; Wojtulewski JA
    Eur J Rheumatol Inflamm; 1992; 12(2):27-30. PubMed ID: 1364935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Open-label tolerability study of enteric-coated naproxen in the treatment of osteoarthritis and rheumatoid arthritis.
    Bellamy N; Beaulieu A; Bombardier C; Esdaile J; Huang S; Jovaisas AV; Khanna VN; Kraag G; Mehta DM; Ménard HA
    Curr Med Res Opin; 1992; 12(10):652-61. PubMed ID: 1633723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 6-month, double-blind study comparing nabumetone to naproxen in the treatment of osteoarthritis.
    Pisko EJ; Strader K; Rice D; White R; Goodman LA
    Pharmatherapeutica; 1987; 5(2):90-8. PubMed ID: 3310020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.